[1] Zhao H, Perez JS, Lu K,et al. Role of Toll-like receptor-4 in renal graft ischemia-reperfusion injury. Am J Physiol Renal Physiol. 2014;306(8):F801-F811.
[2] 薛武军. 影响移植肾和受者长期存活的因素[J].中华器官移植杂志,2013,34(6):377-378.
[3] Rabb H.The T cell as a bridge between innate and adaptive immune systems: implications for the kidney.Kidney Int. 2002; 61(6):1935-1946.
[4] Denecke C, Tullius SG.Innate and adaptive immune responses subsequent to ischemia-reperfusion injury in the kidney.Prog Urol. 2014;24 Suppl 1:S13-19.
[5] Kinsey GR, Sharma R, Okusa MD.Regulatory T cells in AKI.J Am Soc Nephrol. 2013;24(11):1720-1726.
[6] Ventura CG, Coimbra TM, de Campos SB,et al. Mycophenolate mofetil attenuates renal ischemia/ reperfusion injury.J Am Soc Nephrol. 2002;13(10): 2524-2533.
[7] Rabb H, Mendiola CC, Dietz J,et al.Role of CD11a and CD11b in ischemic acute renal failure in rats.Am J Physiol. 1994;267(6 Pt 2):F1052-1058.
[8] De Greef KE, Ysebaert DK, Dauwe S,et al.Anti-B7-1 blocks mononuclear cell adherence in vasa recta after ischemia. Kidney Int. 2001;60(4):1415-1427.
[9] Rabb H, Daniels F, O'Donnell M, et al.Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice.Am J Physiol Renal Physiol. 2000;279(3):F525-531.
[10] Kinsey GR, Sharma R, Huang L,et al. Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury.J Am Soc Nephrol. 2009;20(8):1744-1753.
[11] Burne-Taney MJ, Kofler J, Yokota N,et al.Acute renal failure after whole body ischemia is characterized by inflammation and T cell-mediated injury.Am J Physiol Renal Physiol. 2003; 285(1):F87-94.
[12] Yokota N, Daniels F, Crosson J, et al.Protective effect of T cell depletion in murine renal ischemia-reperfusion injury. Transplantation. 2002;74(6):759-763.
[13] Satpute SR, Park JM, Jang HR,et al.The role for T cell repertoire/antigen-specific interactions in experimental kidney ischemia reperfusion injury.J Immunol. 2009;183(2):984-992.
[14] Erpicum P, Detry O, Weekers L,et al.Mesenchymal stromal cell therapy in conditions of renal ischaemia/reperfusion. Nephrol Dial Transplant. 2014;29(8):1487-1493.
[15] Zhao JJ, Liu JL, Liu L,et al.Protection of mesenchymal stem cells on acute kidney injury.Mol Med Rep. 2014;9(1):91-96.
[16] Duffield JS, Park KM, Hsiao LL,et al. Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. J Clin Invest. 2005;115(7):1743-1755.
[17] Tögel F, Hu Z, Weiss K,et al. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms.Am J Physiol Renal Physiol. 2005;289(1):F31-42.
[18] Chen YT, Sun CK, Lin YC, et al. Adipose-derived mesenchymal stem cell protects kidneys against ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction.J Transl Med. 2011;9:51.
[19] Tögel F, Weiss K, Yang Y, et al. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol. 2007;292(5):F1626-1635.
[20] La Manna G, Bianchi F, Cappuccilli M, et al. Mesenchymal stem cells in renal function recovery after acute kidney injury: use of a differentiating agent in a rat model. Cell Transplant. 2011;20(8):1193-1208.
[21] Hara Y, Stolk M, Ringe J, et al. In vivo effect of bone marrow-derived mesenchymal stem cells in a rat kidney transplantation model with prolonged cold ischemia.Transpl Int. 2011;24(11):1112-1123.
[22] Luz-Crawford P, Kurte M, Bravo-Alegría J, et al.Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells. Stem Cell Res Ther. 2013; 4(3):65.
[23] Lim JY, Park MJ, Im KI,et al.Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.Cell Transplant. 2014;23(6):703-714.
[24] Zheng ZH, Li XY, Ding J,et al.Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.Rheumatology (Oxford). 2008;47(1): 22-30.
[25] Bartholomew A, Sturgeon C, Siatskas M,et al.Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo.Exp Hematol. 2002;30(1): 42-48.
[26] Kim JA, Hong S, Lee B,et al.The inhibition of T-cells proliferation by mouse mesenchymal stem cells through the induction of p16INK4A-cyclin D1/cdk4 and p21waf1, p27kip1-cyclin E/cdk2 pathways.Cell Immunol. 2007;245(1): 16-23.
[27] Uccelli A, Prockop DJ.Why should mesenchymal stem cells (MSCs) cure autoimmune diseases?Curr Opin Immunol. 2010; 22(6):768-774.
[28] Wu T, Zhang L, Xu K,et al. Immunosuppressive drugs on inducing Ag-specific CD4(+)CD25(+)Foxp3(+) Treg cells during immune response in vivo.Transpl Immunol. 2012; 27(1):30-38.
[29] Yang H, Zhang Y, Wu M,et al.Suppression of ongoing experimental autoimmune myasthenia gravis by transfer of RelB-silenced bone marrow dentritic cells is associated with a change from a T helper Th17/Th1 to a Th2 and FoxP3+ regulatory T-cell profile.Inflamm Res. 2010;59(3):197-205.
[30] Zuo D, Liu X, Shou Z,et al.Study on the interactions between transplanted bone marrow-derived mesenchymal stem cells and regulatory T cells for the treatment of experimental colitis.Int J Mol Med. 2013;32(6):1337-1344.
[31] Jun C, Ke W, Qingshu L,et al.Protective effect of CD4(+)CD25(high)CD127(low) regulatory T cells in renal ischemia-reperfusion injury.Cell Immunol. 2014;289(1-2): 106-111.
[32] Gandolfo MT, Jang HR, Bagnasco SM,et al.Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury.Kidney Int. 2009;76(7):717-729.
[33] Mahajan D, Wang Y, Qin X,et al.CD4+CD25+ regulatory T cells protect against injury in an innate murine model of chronic kidney disease.J Am Soc Nephrol. 2006;17(10): 2731-2741.
[34] Lee H, Nho D, Chung HS,et al.CD4+CD25+ regulatory T cells attenuate cisplatin-induced nephrotoxicity in mice.Kidney Int. 2010;78(11):1100-1109. |